Hoogervorst ELJ - Search Results

1

Five cases of malignant melanoma during fingolimod treatment in Dutch patients with MS.

Killestein J, Leurs CE, Hoogervorst ELJ, van Eijk J, Mostert JP, van den Eertwegh AJM, Uitdehaag BMJ. Killestein J, et al. Among authors: hoogervorst elj. Neurology. 2017 Aug 29;89(9):970-972. doi: 10.1212/WNL.0000000000004293. Epub 2017 Aug 2. Neurology. 2017. PMID: 28768850 No abstract available.

2

Comparisons of patient self-report, neurologic examination, and functional impairment in MS.

Hoogervorst EL, van Winsen LM, Eikelenboom MJ, Kalkers NF, Uitdehaag BM, Polman CH. Hoogervorst EL, et al. Neurology. 2001 Apr 10;56(7):934-7. doi: 10.1212/wnl.56.7.934. Neurology. 2001. PMID: 11294932

3

Differential treatment effect on measures of neurologic exam, functional impairment and patient self-report in multiple sclerosis.

Hoogervorst EL, Kalkers NF, van Winsen LML, Uitdehaag BM, Polman CH. Hoogervorst EL, et al. Mult Scler. 2001 Oct;7(5):335-9. doi: 10.1177/135245850100700510. Mult Scler. 2001. PMID: 11724450 Clinical Trial.

4

A study validating changes in the multiple sclerosis functional composite.

Hoogervorst EL, Kalkers NF, Uitdehaag BM, Polman CH. Hoogervorst EL, et al. Arch Neurol. 2002 Jan;59(1):113-6. doi: 10.1001/archneur.59.1.113. Arch Neurol. 2002. PMID: 11790238 Clinical Trial.

5

Safety, tolerability, and efficacy of orally administered cannabinoids in MS.

Killestein J, Hoogervorst EL, Reif M, Kalkers NF, Van Loenen AC, Staats PG, Gorter RW, Uitdehaag BM, Polman CH. Killestein J, et al. Neurology. 2002 May 14;58(9):1404-7. doi: 10.1212/wnl.58.9.1404. Neurology. 2002. PMID: 12011290 Clinical Trial.

6

The INTERMED: a screening instrument to identify multiple sclerosis patients in need of multidisciplinary treatment.

Hoogervorst EL, de Jonge P, Jelles B, Huyse FJ, Heeres I, van der Ploeg HM, Uitdehaag BM, Polman CH. Hoogervorst EL, et al. J Neurol Neurosurg Psychiatry. 2003 Jan;74(1):20-4. doi: 10.1136/jnnp.74.1.20. J Neurol Neurosurg Psychiatry. 2003. PMID: 12486260 Free PMC article.

7

One year changes in disability in multiple sclerosis: neurological examination compared with patient self report.

Hoogervorst EL, Eikelenboom MJ, Uitdehaag BM, Polman CH. Hoogervorst EL, et al. J Neurol Neurosurg Psychiatry. 2003 Apr;74(4):439-42. doi: 10.1136/jnnp.74.4.439. J Neurol Neurosurg Psychiatry. 2003. PMID: 12640058 Free PMC article.

8

Immunomodulatory effects of orally administered cannabinoids in multiple sclerosis.

Killestein J, Hoogervorst EL, Reif M, Blauw B, Smits M, Uitdehaag BM, Nagelkerken L, Polman CH. Killestein J, et al. J Neuroimmunol. 2003 Apr;137(1-2):140-3. doi: 10.1016/s0165-5728(03)00045-6. J Neuroimmunol. 2003. PMID: 12667658

9

The patient's perception of a (reliable) change in the Multiple Sclerosis Functional Composite.

Hoogervorst EL, Kalkers NF, Cutter GR, Uitdehaag BM, Polman CH. Hoogervorst EL, et al. Mult Scler. 2004 Feb;10(1):55-60. doi: 10.1191/1352458504ms972oa. Mult Scler. 2004. PMID: 14760953

10

Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability.

Hoogervorst EL, Zwemmer JN, Jelles B, Polman CH, Uitdehaag BM. Hoogervorst EL, et al. Mult Scler. 2004 Oct;10(5):569-74. doi: 10.1191/1352458504ms1078oa. Mult Scler. 2004. PMID: 15471375

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters